# Biomolecular Markers of Bone Metastasis

> **NCT06806462** · NA · RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 160 (estimated)

## Conditions studied

- Bone Metastasis

## Interventions

- **GENETIC:** Biomolecular profile of bone metastases

## Key facts

- **NCT ID:** NCT06806462
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-17
- **Primary completion:** 2026-06-17
- **Final completion:** 2026-09-17
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06806462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06806462, "Biomolecular Markers of Bone Metastasis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06806462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*